Senior Maintenance Engineer

Job description:

Do you pride yourself on your integrity? We do what’s right for our employees, patients and partners so can you?

 

Oxford Biomedica’s Engineering team are responsible for all aspects of Plant, Mechanical, Electrical, and Incoming utilities at our facilities.

 

We are currently recruiting for a Senior Engineer to ensure maximum equipment availability, assume ownership of critical asset incidents, coordination with resolution parties, and maintain effective communication between stakeholders for post-incident analysis.

Your responsibilities in this role would be:

 

• To personally lead diagnostic activities relating complex equipment faults, liaising internally and externally as required.
• Management of OXB’s external engineering resource in relationship to specialist repairs and maintenance of assets.
• Accountable for verifying and implementing effective maintenance and calibration activities across different asset types.
• Hands on completion of planned and reactive maintenance and calibration activities complete with associated documentation.
• Provide support for implementation of new technology, assets, processes, and products across the business.
• Co-ordinate engineering activities across multiple sites to ensure best practice, highlighting risks and differences. 
• Maintain a safety-first approach to assets and engineering procedures. 
• Maintain awareness of industry technology advancements driving OXB engineering to the forefront of the industry. 
• Identify, lead, and embed engineering process improvements.

Profile description:

We are looking for:

 

• A minimum of HNC (OFQUAL LEVEL 4 or equivalent) in a related Engineering discipline and/or the equivalent work experience in a regulatory environment.
• Advanced electro-mechanical knowledge of complex equipment with proven hands-on experience in technical fault finding and rectification.
• Demonstratable ability to own, understand and resolve complex equipment problems.
• Ability to constructively challenge established ways of working and propose alternatives.
• Experience of influencing, coaching and mentoring others
• Able to use majority of Microsoft Office suite software.
• Proven experience within a GxP Pharmaceutical/Biotech industry is preferred.
• Experience in the introduction of new technology, and production processes is preferred.
• Flexibility with varying day shift patterns & some weekend working

 

 

About Us:

 

Oxford Biomedica is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.

 

Oxford Biomedica collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise.

 

 

What’s in it for you:

 

• Highly competitive total reward packages
• Wellbeing programmes
• Development opportunities
• Welcoming, friendly, supportive colleagues
• A diverse and inclusive working environment
• Our values are: Deliver Innovation, Be Inspiring and Have Integrity
• State of the art laboratory and manufacturing facilities

 

We want you to feel inspired every day. We’re future-focused and our business is growing rapidly. We succeed together through passion, commitment, and teamwork, and so can you.

 

Collaborate. Contribute. Change lives.

We offer:

Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.  

 

Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).  

 

Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.